Combinatorial mutagenesis and in vivo selection experiments previously afforded functional variants of the AroH class Bacillus subtilis chorismate mutase lacking the otherwise highly conserved active site residue Arg 90 . Here, we present a detailed kinetic and crystallographic study of several such variants. Removing the arginine side chain (R90G and R90A) reduced catalytic efficiency by more than five orders of magnitude. Reintroducing a positive charge to the active site through lysine substitutions restored more than a factor of a thousand in k cat .
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suggests that the transition state of the enzyme-catalyzed process is more highly polarized than that of the uncatalyzed reaction (22) . Electrostatic interactions may therefore be essential for efficient catalysis (8, 23) . Complementarily charged active site residues could conceivably stabilize developing charges in transition state 2 (Fig. 1A) . Computational studies have highlighted stabilizing interactions between the positively charged Arg at position 90 of BsCM and the partially negatively charged ether oxygen of chorismate in the transition state (17, 18, 24) .
In previous work, we addressed the hypothesis of electrostatic catalysis by combinatorial mutagenesis experiments (25, 26 ). An evolutionary approach was employed consisting of randomizing critical positions in the active site of BsCM combined with direct genetic selection for mutant genes encoding functional catalysts. From the spectrum of active BsCM mutants obtained it was obvious that survival of host cells under selective conditions was only possible for variants with a positively charged group in the region of the ether oxygen of bound chorismate (25) . Here, we report detailed kinetic and structural characterization of several relevant mutant enzymes derived from our combinatorial libraries. The results suggest that a single cation provides the dominant catalytic interaction in the active site of chorismate mutases.
EXPERIMENTAL PROCEDURES
Materials-Chorismic acid was prepared according to published procedures (27) . The transition state analog for the chorismate mutase reaction, the oxabicyclic dicarboxylic acid 4 of DNA ligase were purchased from New England Biolabs (Beverly, MA) and pfu DNA polymerase from Stratagene (La Jolla, CA) was used for PCR.
Strains and Plasmids-E. coli strain KA13 (13, 29) was used for the construction of the aroH expression plasmids as well as for BsCM protein production. The in vivo complementation system KA12/pKIMP-UAUC was described previously (25) . Both KA13 and KA12 have chromosomal deletions of the endogenous E. coli chorismate mutase genes.
by guest on November 6, 2017 http://www.jbc.org/ Downloaded from 6 The cloning vector pET-22b(+) was from Novagen (Madison, WI). Plasmids pKCMT-W, pKCMT-R90A, pKCMT-R90G, pKCMT-C88S/R90K and pKCMT-C88K/R90S carry trc promoter-expressed B. subtilis aroH gene variants encoding wild-type (WT), R90A, R90G, C88S/R90K and C88K/R90S BsCM, respectively. pKCMT-W and the selected mutant pKCMT-plasmids from two different combinatorial libraries were characterized previously (25) .
pKET3-W (21) is a pET-22b(+) derivative which contains the WT aroH gene under the control of the T7 RNA polymerase promoter.
In Vivo Phenotypic Analyses-Individual mutant aroH genes were tested for their ability to complement the chorismate-mutase deficiency of strain KA12 after transforming KA12/pKIMP-UAUC with the relevant pKCMT-plasmids. The assay procedure involved comparing growth of single colonies on minimal medium (M9c) agar plates in the presence or absence of 20 µg/ml L-Phe and L-Tyr. M9c plates were composed of 1 × M9 salts [Na 2 HPO 4 (6 mg/ml)/KH 2 PO 4 (3 mg/ml)/NH 4 Cl (1 mg/ml)/NaCl (0.5 mg/ml), pH 7.0; (30)] supplemented with 0.2% (w/v) D-(+)-Glc/1 mM MgSO 4 /0.1 mM CaCl 2 /thiamine-HCl (5 µg/ml)/4-hydroxybenzoic acid (5 µg/ml)/4-aminobenzoic acid (5 µg/ml)/2,3-dihydroxybenzoic acid (1.6 µg/ml)/L-Trp (20 µg/ml)/sodium ampicillin (100 µg/ml)/chloramphenicol (20 µg/ml) and 15 g agar per liter. Media and assay conditions corresponded to those used previously (25) .
Construction of Chorismate Mutase Gene Expression Plasmids-For high-level production
of mutant BsCM proteins, the corresponding aroH genes were transferred from the initial trc promoter expression plasmids (pKCMT-types) to pET-22b(+) allowing for T7 promoterdriven gene expression. The aroH genes for C88S/R90K or C88K/R90S variants were amplified by PCR with oligonucleotides T7-aroHW (5'-GGAAACAGCATATGATGATTCGCGGAATT) and TMUTN (5'-ATCAAGCGGCCGCACTAGT) using HincII-digested pKCMT-C88S/R90K or pKCMT-C88K/R90S as templates, respectively. The 414 bp PCR products were digested with NdeI and EagI to yield 394 bp fragments that were then ligated to the 5372 bp NdeI-EagI fragment of 7 R90A and pKET3-R90G were obtained by replacing the 343 bp EcoRI-HindIII restriction fragment in pKET3-W with the corresponding fragments from pKCMT-R90A and pKCMT-R90G, respectively. We have observed that a single silent base change in the codon for Ile 3 (from ATC to ATT) caused a three-fold increase in WT protein yield (data not shown), even though codon usage in highly expressed genes in E. coli favors ATC (83%) over ATT (17%) (according to Version 8 of the program package by Genetics Computer Group, Inc, Madison, WI). Consequently, the third codon in aroH on the pKCMT-plasmids (ATC) was mutated to ATT in all pKET3-constructs. The entire aroH gene and relevant gene expression signals in the new pKET3-plasmids (5766 bp) were confirmed by sequencing both strands with primers T7PRO2 (5'-TAATACGACTCACTATAGGG) and T7TER (5'-CAGCAGCCAACTCAGCT) using an ABI 373 DNA sequencer (Perkin Elmer, Norwalk, CT) with dye terminator nucleotides and chain termination chemistry (31) . All DNA manipulations were carried out according to standard procedures (32) .
Overproduction and Purification of BsCM Variants-5 ml LB-medium (30) containing 150
µg/ml sodium ampicillin were inoculated with a single colony of E. coli strain KA13 transformed with the relevant pKET3-plasmid and incubated overnight at 37 °C. 1 l of the same medium with 150 µg/ml sodium ampicillin was seeded with the densely grown preculture and shaken at 250 rpm at 37 °C until an OD 600nm of 0.6 was reached. Then, isopropyl-β-Dthiogalactopyranoside was added (500 µM final concentration) to induce synthesis of the chromosomally encoded T7 RNA polymerase in KA13 for expression of the T7 promotercontrolled aroH genes. The incubation was continued for another 24 h. The structure of monomer A of the published wild-type protein [PDB # 2CHT, (7, 8) ] was used as the search model for molecular replacement. Molecular replacement was performed using X-PLOR (35) and AMoRe (36) in separate runs. Both programs yielded virtually the same solutions, which were verified by inspecting the resulting electron density maps. The structures were subsequently refined with X-PLOR (35,37) using torsion-angle dynamics (38) .
For the final rounds of refinement, data were restricted to 1.9 Å and 2.0 Å for the mutants C88S/R90K and C88K/R90S, respectively, because beyond that resolution both R and R free increased dramatically. Model building was carried out on a molecular graphics workstation using O (39) . 
RESULTS

Selection, Overproduction and Purification of BsCM variants-Previous in vivo studies of
mutant BsCM genes indicated that a positively charged amino acid side chain at position 90 or 88 is a prerequisite for detectable chorismate mutase activity (25) . To assess and quantify the role of this cation for the enzymatic mechanism, we have examined several BsCM variants in greater detail. The corresponding aroH genes were taken from our collection of mutants generated for the combinatorial mutagenesis and selection experiments (25) , and their phenotype was redetermined (Table I) .
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The subset of enzymes chosen here includes two variants in which the positively charged guanidinium group at position 90 is absent (R90A and R90G). Both of these proteins are completely inactive in vivo (Table I) . All active aroH genes isolated from libraries in which positions 88 or 90 were randomized fell into three general groups: (i) Arg 90 was retained with no preference for a specific residue at position 88; (ii) Arg 90 was replaced by Lys and an amino acid smaller than Cys was selected at position 88; (iii) Cys 88 was replaced by Lys and several smaller residues were permitted in place of Arg 90 (25) . We included two representatives of the latter two classes, C88S/R90K and C88K/R90S, for in-depth analysis. Both variants were confirmed to be functional in vivo (Table I ) and thus possess catalytically competent active sites.
In contrast, the single mutant R90K, which was characterized previously (41), was not sufficiently active in vivo to permit growth under selective conditions.
The relevant aroH mutant genes were recloned and overexpressed in E. coli strain KA13 which is devoid of endogenous chorismate mutase activity. The encoded BsCM variants were subsequently purified in native form by an osmotic shock procedure and anion exchange chromatography in yields ranging from 60 to 120 mg/l of culture. The final preparations were homogeneous as judged by SDS-polyacrylamide gel electrophoresis. Mass spectrometry confirmed the integrity of the samples, but also indicated that 5-10% of the purified protein lacked the N-terminal Met (data not shown). This proteolytic processing, which probably occurred in vivo during protein biosynthesis, was observed previously with preparations of WT BsCM but did not seem to affect the kinetic data (15) . Circular dichroism spectra (260-200 nm) of R90G and R90A were superimposable on that of WT BsCM (data not shown), indicating that overall secondary structure was not significantly perturbed by the mutations. The integrity of the three-dimensional structures, including active site geometries, was confirmed by X-ray crystallographic studies of R90G and R90A (unpublished data by U. Krengel) as well as C88S/R90K and C88K/R90S (see below).
Kinetic Characterization of BsCM variants-
The catalytic rate constant k cat and the Michaelis constant K m obtained for the purified BsCM variants are summarized in Table II. Since no mutase activity above the thermal background rearrangement of chorismate was 12 detected for R90A, even at high concentrations of protein, k cat could not be determined for this variant; so only an upper limit for k cat /K m can be estimated (Table II) . In contrast, the R90G sample shows very low but detectable chorismate mutase activity with a k cat value more than five orders of magnitude lower than that for the WT enzyme. 3 In the double mutants C88S/R90K and C88K/R90S, a cation is added back to the active site and significant activity is recovered. The catalytic rate constants (k cat ) are increased by three orders of magnitude relative to R90G, to values only 150-fold below WT BsCM (Table II) .
Substantial increases in K m for chorismate (64 and 28-fold relative to WT, for C88S/R90K and C88K/R90S, respectively), however, suggest structural changes that affect ligand binding.
Although several fold smaller than K s for the WT enzyme, K m is likely to be a direct measure of substrate affinity in the variants (21) . As a result of these combined effects, the catalytic proficiencies of both double mutants are between 10 3 -10 4 -fold lower than that of WT BsCM.
It is interesting to note that the double mutant C88K/R90S with the more severely redesigned active site (cation relocated from position 90 to 88) is 2 to 3-fold more proficient than the more conservative, but isosteric catalyst C88S/R90K.
Binding of a Transition State Analog
Inhibitor-Kinetic assays in the presence of the competitive inhibitor 4 (Fig. 1B) yielded a dissociation constant (K i ) of 3.0 ± 0.4 µM, in excellent agreement with published data for the WT enzyme (43) . R90G has a somewhat larger (Table II) (Fig. 2B) , but its ammonium group faces away from the substrate binding pocket and engages in a salt bridge with Glu 78 . An interaction of the ammonium group with the transition state appears possible (Fig. 4) , but would require some rearrangement of the side chains of Lys 90 and Glu 78 upon ligand binding. Similarly, the guanidinium group of Arg 7 needs to be repositioned in the mutant enzyme for productive substrate (and transition state) binding through salt bridges between the guanidinium and carboxylate groups. The sample used for crystallization shows some oxidation of Cys 75 , apparently to the sulfenate, as deduced by mass spectroscopy and the electron density maps (Fig. 2A) . Increasing the DTT concentration in the crystallization medium (up to 40 mM) did not fully reduce this residue to the sulfhydryl, as judged from electron density maps calculated from additionally collected data (not shown). However, recent X-ray structural data collected on a fresh batch of mutant C88S/R90K show that oxidation of Cys 75 can be prevented with sufficiently high DTT concentrations throughout protein purification, storage and handling. The three-dimensional structure of unoxidized C88S/R90K (preliminary refinement to 2.1 Å resolution, data not shown) is very similar to that reported here, except for the lack of electron density for oxygen at the Cys 75 side chain. While a cation appears to be required for catalytic activity (25) , the choice of a guanidinium or the chemically distinct ammonium ion is less important. Moreover, similar rescue efficiencies are obtained when the ammonium is provided from either position 88 or 90. The crystal structures of the double mutants show that the respective lysine side chains extend into the active site, where they would be available for productive electrostatic interactions with the ether oxygen in the transition state (Fig. 4) . These results are consistent with the notion that the cationic residue stabilizes developing negative charge on the ether oxygen in the transition state (8, 22, 25) , although an additional role in helping to fix the flexible, negatively charged substrate in a reactive conformation cannot be excluded (20) .
It is evident from the crystal structures of the double mutants that the modified active sites are suboptimal for substrate and transition state binding. In particular, both Arg 7 and Glu 78 , which are normally involved in prominent interactions with ligand (Fig. 4) , do not superimpose well on the WT structure (Figs. 2B and 3B) . The absence of a ligand in these structures is unlikely to account for the observed differences, since, with the exception of the C-terminal tail beyond Leu 115 , ligand binding to WT BsCM does not significantly affect protein conformation (8) .
The substantial conformational reorganization required of Arg 7 and Glu 78 to bind chorismate (as modeled in Fig. 4) , especially the need to break the salt bridge between Glu 78 and the lysine at position 88 or 90, presumably contributes to the large increases in K m seen for these mutants and hence to the large reductions in catalytic proficiency. (Table II) . Because 4 mimics the dissociative character of the transition state less well than its geometry, it is not surprising that the transition state analog's affinity is less sensitive to mutation of the cationic group than that of the polarized transition state.
The kinetic consequences of removing the guanidinium group of Arg 90 in BsCM are comparable to those observed with other enzymes that exploit an arginine to stabilize oxyanionic intermediates and transition states electrostatically. For example, high-resolution crystal structures of the metalloprotease carboxypeptidase A suggest that Arg 127 interacts electrostatically with the tetrahedral oxyanion formed during peptide bond hydrolysis (44) .
Consistent with this view, the k cat value for the cleavage of Cbz-Phe-Ala-Phe decreases 96-fold when Arg 127 is replaced by lysine, and 8000-fold upon substitution with alanine (45) . The decrease in the k cat /K m parameter was found to be 2400 and 1.3 x 10 5 -fold for the R127K and R127A mutants, respectively (45) . Thus, despite individual differences in the oxyanionic character of the transition states for amide hydrolysis and Claisen rearrangement, effects of similar magnitude are achieved upon mutagenizing the complementary cationic group on the two enzymes.
How general might cation-assisted electrostatic catalysis in chorismate mutases be? All available sequences for natural chorismate mutases fall either into the AroH or the AroQ class (13) . Even though these two protein families share no resemblance in their primary or tertiary structures (7-11), their active sites are remarkably similar (20) . In particular, AroQ enzymes have an absolutely conserved lysine residue (13, 46) , which in the structurally characterized E. coli [Lys 39 (9) ] and Saccharomyces cerevisiae [Lys 168 (11) ] chorismate mutases occupies an equivalent position to Arg 90 in the AroH enzymes. This lysine donates a hydrogen bond to the ether oxygen of bound transition state analog 4 and could thus stabilize the true transition state electrostatically, as postulated for Lys 90 or Lys 88 in the BsCM double mutants (Fig. 4) . Sitedirected mutagenesis studies with the E. coli AroQ p chorismate mutase (EcCM) have confirmed that this residue is crucial for activity (47, 48) . Although there are significant discrepancies for the reported values for k cat /K m and K m of individual mutants, replacement of Lys 39 by Arg, Ala, Gln and Asn reduces catalytic proficiency by at least three and up to five orders of magnitude (47, 48) . Thus, irrespective of individual differences in activation parameters (14, 15, 49) , isotope effects (3, 22) , and sensitivity to changes in viscosity (21) , chorismate mutases from both the AroH and AroQ classes share a requirement for a positively charged residue close to the ether oxygen of rearranging chorismate.
Interestingly, a catalytic antibody with modest chorismate mutase activity appears to lack this feature. Antibody 1F7 was generated in response to inhibitor 4 and enantioselectively catalyzes the rearrangement of chorismate to prephenate, albeit 10 4 -times less efficiently than the natural enzymes (50, 51) . In contrast to natural mutases, interactions between antibody residues and the ether oxygen of transition state analog 4 are not observed in the crystal structure of the Fab'•4 complex (23) . The only cationic residue in the binding pocket, Arg H95 , forms a salt bridge with the secondary carboxylate of the inhibitor and is too far from the ether oxygen to provide significant electrostatic stabilization to developing negative charge in the transition state (23) .
The absence of such an interaction may thus explain the relatively poor activity of the antibody.
Such a rationalization suggests obvious strategies for producing more active catalysts. The requisite cation might be directly engineered into the 1F7 active site using site-directed mutagenesis. Alternatively, in vivo selection may prove more fruitful. While the genes for the 1F7 Fab fragment do not yet provide sufficient catalytic activity to promote growth under selective conditions in the E. coli complementation system used to study BsCM, 5 they weakly complement a chorismate mutase-deficient yeast strain (52) . Combinatorial mutagenesis and in vivo selection, initially with the yeast and then with the more tractable E. coli system, could conceivably deliver the crucial catalytic functionality and improve this still poor man-made catalyst. and C88K/R90S can be accessed under PDB # 1FNJ and PDB # 1FNK, respectively. 3 Accidental, low-level contamination of the R90G preparation by wild-type BsCM during isolation is highly unlikely because five independently cultured and purified batches of the enzyme had very similar Michaelis-Menten parameters. It remains possible, however, that the Gly codon (GGC) in the R90G gene is suppressed in vivo at an extremely low level by a mispairing tRNA Arg (53) . For this reason, the k cat and k cat /K m values reported in Table I should be considered as upper limits on the activity of this mutant. 4 The choice of residue at position 88 may, for steric reasons (i.e. due to the relief of packing constraints), enable the Lys side chain to assume a catalytically competent conformation. For Table I Features of BsCM variants relevant to this study Listed are the amino acids at the randomized positions 88 and 90 of relevant BsCM variants.
The in vivo phenotype refers to growth (colony size) on minimal agar plates of the bacterial host system transformed with the respective aroH gene variants. The genetic complementation system was described previously (25 
